Patient Care and Research

Letter of Intent Workshop

Saturday, October 20, 2018, 9:00 a.m. - 12:00 p.m. Central time

Letters of Intent (LOI) for phase 0 and phase 1 clinical trials are an essential part of the clinical trial protocol development process. A LOI is the first step in the application process that precedes the submission of a trial protocol. Without a successful LOI, the effort to write a clinical trial protocol will be wasted. 

At the 2017 ASTRO Immunotherapy Workshop, we held our first Letter of Intent Writing Workshop, meant to educate our members on how to plan and design successful clinical trials and write the all-important Letter of Intent in order to start such a trial.

Workshop Led By:

Charles Kunos, MD, National Cancer Institute
Jeffrey Buchsbaum, MD, National Cancer Institute

Dow-Chung Chi, Food and Drug Administration

Previous Letter of Intent Writing Workshops:

Friday, July 27, 2018, 1:00 p.m. - 5:00 p.m. Eastern time